Received Nov 26, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAPIPV | DTAP + IPV (KINRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 52D72 | LL |
4-month-old patient received Kinrix; received Kinrix instead of Pediarix; This non-serious case was reported by a nurse via call center representative and described the occurrence of inappropriate age at vaccine administration in a 4-month-old male patient who received DTPa-IPV (Kinrix) (batch number 52D72, expiry date 19-OCT-2026) for prophylaxis. Co-suspect products included DTPa-HBV-IPV (Pediarix) for prophylaxis. Concomitant products included Pneumococcal vaccine conj 20v (CRM197) (Prevnar 20), Rotavirus vaccine live reassort oral 5v (Rotateq) and HIB vaccine conj (tet tox) (Act hib). On 18-NOV-2025, the patient received Kinrix (left thigh) .5 ml. The patient did not receive Pediarix. On 18-NOV-2025, an unknown time after receiving Kinrix, the patient experienced inappropriate age at vaccine administration (Verbatim: 4-month-old patient received Kinrix) and wrong vaccine administered (Verbatim: received Kinrix instead of Pediarix). The outcome of the inappropriate age at vaccine administration and wrong vaccine administered were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 18-NOV-2025 The reporter stated that Kinrix was administered, however, the intended vaccine was Pediarix (medication error).
PREVNAR 20; ROTATEQ; ACT HIB